Locations:
Search
The BTK inhibitor tolebrutinib meets its primary endpoint in phase 3 HERCULES trial
Meaningful characterization is critical to advancing research and care, review authors contend
Guidance from international committee on differential diagnoses and diagnostic approach
Investigational gene approaches offer hope for a therapeutically challenging condition
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
$3.2 million grant will fund use of calcium-based imaging to record neuronal activity in ischemia model
Findings from large cohort analysis can guide ongoing quality improvement initiatives
New phase 1 trial showcases Neurological Institute’s interdisciplinary study capabilities
Helping patients, families navigate the complexities of psychosis
A range of pituitary tumor-related conditions all benefit from a multidisciplinary approach
Researchers use patient data to strengthen clinical prediction models
Advertisement
Advertisement